Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
See the AAAaAI review, a related PubMed case series and an FDA pharmacovigilance memo for more detail
The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
31G is thinner than 18G)
An extreme lipotropic (fat loving) injection is a specialized formula designed to support weight management and enhance metabolic function
Chromatogram review does not replace identity testing
Check again in five minutes
US$ 25.67
US$ 26.11
US$ 27.65
US$ 27.39
US$ 28.36
US$ 25.04
US$ 29.57
US$ 28.09
US$ 21.62
US$ 28.71
US$ 27.11
